Is age ≥ 70 years an important predictor...

Journal of Geriatric Oncology 2012 Vol. 3; Iss. 4

Is age ≥ 70 years an important predictor of adverse events among patients enrolled in metastatic melanoma trials? Findings from pooled analyses of therapeutic trials

Aminah Jatoi, Jacob B. Allred, Vera J. Suman, Edward T. Creagan, Gary A. Croghan, Thomas Amatruda, Svetomir N. Markovic
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Year:
2012
Language:
english
DOI:
10.1016/j.jgo.2012.04.002
File:
PDF, 293 KB
english, 2012
Conversion to is in progress
Conversion to is failed